Acta Med. 2004, 47: 33-35

https://doi.org/10.14712/18059694.2018.63

Adenosine Deaminase Activity in the Serum of Type 2 Diabetic Patients

Naciye Kurtula, Sadrettin Pençeb, Ersin Akarsuc, Hasan Koçoğlud, Yemliha Aksoye, Hülya Aksoyf

aUniversity of Sütcü Imam, Faculty of Science, Department of Chemistry, Kahramanmaraş, Turkey
bUniversity of Gaziantep, Faculty of Medicine, Department of Physiology, Gaziantep, Turkey
cUniversity of Gaziantep, Faculty of Medicine, Department of Endocrinology and Metabolism, Gaziantep, Turkey
dUniversity of Gaziantep, Faculty of Medicine, Department of Anesthesiology and Reanimation, Gaziantep, Turkey
eState Hospital of Gaziantep, Department of Emergency and First Aid, Gaziantep, Turkey
fUniversity of Atatürk, Faculty of Medicine, Department of Biochemistry, Erzurum, Turkey

Received March 1, 2003
Accepted October 1, 2003

Crossref Cited-by Linking

  • Battal Abdulhamit, Dogan Abdulahad, Uyar Ahmet, Demir Abdulbaki, Keleş Ömer Faruk, Celik Ismail, Baloglu Mehmet Cengiz, Aslan Ali: Exploring of the ameliorative effects of Nerium (Nerium oleander L.) ethanolic flower extract in streptozotocin induced diabetic rats via biochemical, histological and molecular aspects. Mol Biol Rep 2023, 50, 4193. <https://doi.org/10.1007/s11033-023-08332-5>
  • de Lima André Campos, Chaves Lucas Macedo, Prestes Samantha Nuncio, Mânica Aline, Cardoso Andreia Machado: The purinergic signalling and inflammation in the pathogenesis and progression of diabetes: key factors and therapeutic targets. Inflamm. Res. 2022, 71, 759. <https://doi.org/10.1007/s00011-022-01587-x>
  • Zhou Yu, Jin Wei-Dong, Pang Zhen-Zhen, Xia Jun, Chen Su-Feng: The value of adenosine deaminase activity in latent autoimmune diabetes in adults and type 2 diabetes patients. Int J Diabetes Dev Ctries 2021, 41, 48. <https://doi.org/10.1007/s13410-020-00864-x>
  • Akhigbe R.E., Ajayi L.O., Ajayi A.F.: Codeine exerts cardiorenal injury via upregulation of adenine deaminase/xanthine oxidase and caspase 3 signaling. Life Sciences 2021, 273, 118717. <https://doi.org/10.1016/j.lfs.2020.118717>
  • Divya Kakara, Malothu Ramesh, Narayana E. Laxmi: BDNF is obverse to oxidative stress (adenosine deaminase and nitric oxide) in type II diabetes mellitus. Int J Diabetes Dev Ctries 2020, 40, 390. <https://doi.org/10.1007/s13410-019-00793-4>
  • Ow Jin Rong, Caldez Matias J, Zafer Gözde, Foo Juat Chin, Li Hong Yu, Ghosh Soumita, Wollmann Heike, Cazenave-Gassiot Amaury, Ong Chee Bing, Wenk Markus R, Han Weiping, Choi Hyungwon, Kaldis Philipp: Remodeling of whole-body lipid metabolism and a diabetic-like phenotype caused by loss of CDK1 and hepatocyte division. eLife 2020, 9. <https://doi.org/10.7554/eLife.63835>
  • Omolekulo Tolulope Eniola, Michael Olugbenga Samuel, Olatunji Lawrence Aderemi: Sodium acetate improves disrupted glucoregulation and hepatic triglyceride content in insulin-resistant female rats: involvement of adenosine deaminase and dipeptidyl peptidase-4 activities. Naunyn-Schmiedeberg's Arch Pharmacol 2019, 392, 103. <https://doi.org/10.1007/s00210-018-1569-2>
  • Dangana Elizabeth O., Michael Olugbenga S., Omolekulo Tolulope E., Areola Emmanuel D., Olatunji Lawrence A.: Enhanced hepatic glycogen synthesis and suppressed adenosine deaminase activity by lithium attenuates hepatic triglyceride accumulation in nicotine-exposed rats. Biomedicine & Pharmacotherapy 2019, 109, 1417. <https://doi.org/10.1016/j.biopha.2018.10.067>
  • Omolekulo Tolulope Eniola, Michael Olugbenga Samuel, Olatunji Lawrence Aderemi: Dipeptidyl peptidase-4 inhibition protects the liver of insulin-resistant female rats against triglyceride accumulation by suppressing uric acid. Biomedicine & Pharmacotherapy 2019, 110, 869. <https://doi.org/10.1016/j.biopha.2018.12.036>
  • Bagheri S., Saboury A.A., Haertlé T.: Adenosine deaminase inhibition. International Journal of Biological Macromolecules 2019, 141, 1246. <https://doi.org/10.1016/j.ijbiomac.2019.09.078>
  • Kahraman Seda, Eroglu Altinova Alev, Elgun Serenay, Yalcin Mehmet Muhittin, Aktas Yilmaz Banu, Ozkan Cigdem, Akturk Mujde, Balos Toruner Fusun: Serum activities of dipeptidyl peptidase-4 and adenosine deaminase in polycystic ovary syndrome: association with obesity. Gynecological Endocrinology 2019, 35, 714. <https://doi.org/10.1080/09513590.2019.1581165>
  • Omolekulo Tolulope Eniola, Areola Emmanuel Damilare, Badmus Olufunto Olayinka, Michael Olugbenga Samuel, Kim Inkyeom, Olatunji Lawrence Aderemi: Inhibition of adenosine deaminase and xanthine oxidase by valproic acid abates hepatic triglyceride accumulation independent of corticosteroids in female rats treated with estrogen–progestin. Can. J. Physiol. Pharmacol. 2018, 96, 1092. <https://doi.org/10.1139/cjpp-2018-0231>
  • Niraula A., Thapa S., Kunwar S., Lamsal M., Baral N., Maskey R.: Adenosine deaminase activity in type 2 diabetes mellitus: does it have any role?. BMC Endocr Disord 2018, 18. <https://doi.org/10.1186/s12902-018-0284-9>
  • Sapkota Lokendra Bahadur, Thapa Sangita, Subedi Nuwadatta: Correlation study of adenosine deaminase and its isoenzymes in type 2 diabetes mellitus. BMJ Open Diab Res Care 2017, 5, e000357. <https://doi.org/10.1136/bmjdrc-2016-000357>
  • Peruvankuzhiyil Farija, Madhavan Lavanya, Joseraj Manaloor George: ADENOSINE DEAMINASE ACTIVITY IN TYPE 2 DIABETES MELLITUS. jebmh 2017, 4, 238. <https://doi.org/10.18410/jebmh/2017/46>
  • Turkal Rana, Bahadır Göksel, Döventaş Yasemin Erdoğan, Haklar Goncagül, Şirikçi Önder, Koldaş Macit: Adenosine deaminase activity and zinc levels in the serum of patients with diabetes mellitus. Turkish Journal of Biochemistry 2016, 41, 423. <https://doi.org/10.1515/tjb-2016-0137>
  • Calgaroto Nicéia Spanholi, da Costa Pauline, Cardoso Andréia Machado, Pereira Luciane Belmonte, Vieira Juliano Marchi, Dalenogare Diéssica, Pelinson Luana Paula, Baldissarelli Jucimara, Morsch Vera Maria, Schetinger Maria Rosa Chitolina: Vitamin D3 prevents the increase in ectonucleotidase activities and ameliorates lipid profile in type 1 diabetic rats. Mol Cell Biochem 2015, 405, 11. <https://doi.org/10.1007/s11010-015-2390-6>
  • Domingos A. C. B., Iacida E. C., de Oliveira R. M., Bonini-Domingos C. R., Brandao de Mattos C. d. C., de Mattos L. C.: Type-2 diabetes mellitus and the frequency of the G22A polymorphism of the adenosine deaminase gene in a mixed population in Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 2014, 108, 439. <https://doi.org/10.1093/trstmh/tru076>
  • Lee Jae-Geun, Kang Dong Gu, Yu Jung Re, Kim Young Ree, Kim Jin Soek, Koh Gwan Pyo, Lee Dae Ho: Changes in Adenosine Deaminase Activity in Patients with Type 2 Diabetes Mellitus and Effect of DPP-4 Inhibitor Treatment on ADA Activity. Diabetes Metab J 2011, 35, 149. <https://doi.org/10.4093/dmj.2011.35.2.149>
  • Mokhtari Mojgan, Hashemi Mohammad, Yaghmaei Minoo, Molashahi Fariba, Shikhzadeh Abdolsamad, Niazi Abbasali, Ghavami Saeid: Serum adenosine deaminase activity in gestational diabetes mellitus and normal pregnancy. Arch Gynecol Obstet 2010, 281, 623. <https://doi.org/10.1007/s00404-009-1148-3>
  • Bopp A., De Bona K.S., Bellé L.P., Moresco R.N., Moretto M.B.: Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients. Fundamemntal Clinical Pharma 2009, 23, 501. <https://doi.org/10.1111/j.1472-8206.2009.00700.x>
  • Patil Neela, Chavan Vishwas, Karnik N. D.: Antioxidant status in patients with acute myocardial infarction. Indian J Clin Biochem 2007, 22, 45. <https://doi.org/10.1007/BF02912880>
  • Amoli Mahsa M., Amiri Parvin, Namakchian Mahsa, Saeid Nejad Roya, Fakhrzadeh Hossein, Heshmat Ramin, Mehraban Nahid, Aryani Kashani Arian, Yaghmaie Parichehr, Tavakkoly Bazzaz Javad, Larijani Bagher: Adenosine deaminase gene polymorphism is associated with obesity in Iranian population. Obesity Research & Clinical Practice 2007, 1, 173. <https://doi.org/10.1016/j.orcp.2007.06.001>
Crossref Cited-by Linking logo